First Niagara Bank’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-3,395
| Closed | -$222K | – | 194 |
|
|
2015
Q4 | $222K | Buy |
+3,395
| New | +$222K | 0.06% | 181 |
|
|
2015
Q2 | – | Sell |
-4,181
| Closed | -$261K | – | 245 |
|
|
2015
Q1 | $261K | Sell |
4,181
-61
| -1% | -$3.81K | 0.06% | 199 |
|
|
2014
Q4 | $244K | Sell |
4,242
-14,385
| -77% | -$827K | 0.05% | 208 |
|
|
2014
Q3 | $1M | Sell |
18,627
-100
| -0.5% | -$5.38K | 0.21% | 102 |
|
|
2014
Q2 | $982K | Sell |
18,727
-1,050
| -5% | -$55.1K | 0.2% | 106 |
|
|
2014
Q1 | $1.05M | Sell |
19,777
-8,815
| -31% | -$466K | 0.21% | 105 |
|
|
2013
Q4 | $1.15M | Sell |
28,592
-2,559
| -8% | -$103K | 0.22% | 99 |
|
|
2013
Q3 | $1.18M | Sell |
31,151
-525
| -2% | -$19.8K | 0.25% | 93 |
|
|
2013
Q2 | $1.24M | Buy |
+31,676
| New | +$1.24M | 0.26% | 88 |
|